Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.65 |
| ▸ | LNPEP | Q9UIQ6 | 3/20 | 0.65 |
| ▸ | MMP2 | P08253 | 1/20 | 0.57 |
| ▸ | GNPAT | O15228 | 1/20 | 0.57 |
| ▸ | ECE1 | P42892 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.53 |
| ▸ | CTSC | P53634 | 1/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | XIAP | P98170 | 1/20 | 0.51 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28540087 | 1.00 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATECE1 | |
| SCHEMBL1711485 | 1.00 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATECE1 | |
| SCHEMBL9747671 | 1.00 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATECE1 | |
| SCHEMBL29382413 | 1.00 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATECE1 | |
| SCHEMBL29372662 | 1.00 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATECE1 | |
| SCHEMBL29356104 | 0.99 | ERAP2 (0.64) | ERAP2LNPEPMMP2GNPATECE1 | |
| SCHEMBL29630365 | 0.97 | ERAP2 (0.62) | ERAP2LNPEPMMP2GNPATECE1 | |
| SCHEMBL7120877 | 0.97 | ERAP2 (0.62) | ERAP2LNPEPMMP2GNPATECE1 | |
| SCHEMBL1711765 | 0.96 | GNPAT (0.63) | ERAP2LNPEPMMP2GNPATECE1 | |
| SCHEMBL1711591 | 0.96 | GNPAT (0.63) | ERAP2LNPEPMMP2GNPATECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3205 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144882-A1 | ANTI-NECTIN-4 ANTIBODY DRUG CONJUGATE AND USE THEREOF | BIO-THERA SOLUTIONS, LTD. (CN) | 2026-05-28 | — | — | US | claimed |
| EP-4748396-A1 | PHARMACEUTICAL COMPOSITION CONTAINING ANTI-NECTIN4 ANTIBODY-DRUG CONJUGATE AND ANTI-PD-1 ANTIBODY AND USE THEREOF | Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. (CN) | 2026-05-27 | — | — | EP | claimed |
| WO-2026103740-A1 | CEACAM5-ANTIGEN-TARGETING ANTIBODY, ANTIBODY-DRUG CONJUGATE THEREOF AND USE THEREOF | 信达生物医药科技(杭州)有限公司 | 2026-05-21 | — | — | WO | claimed |
| WO-2026098441-A1 | COMPOSITION AND METHOD FOR CANCER TREATMENT USING POLYPEPTIDE CONJUGATES | SUZHOU SMARTNUCLIDE BIOPHARMACEUTICAL CO., LTD. (CN) | 2026-05-15 | — | — | WO | claimed |
| EP-4739347-A1 | CONJUGATES OF DRUG UNITS AND TARGETING UNITS AND PRECURSOR COMPOUNDS THEREOF | Solve Therapeutics, Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| EP-3972649-B1 | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NOVARTIS AG (CH) | 2026-05-13 | — | — | EP | claimed |
| CN-122028936-A | Antibody-drug conjugates | ADC疗法责任有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260124212-A1 | MAYTANSINOID DERIVATIVES WITH SELF-IMMOLATIVE PEPTIDE LINKERS AND CONJUGATES THEREOF | IMMUNOGEN INC (US) | 2026-05-07 | — | — | US | claimed |
| US-20260115333-A1 | CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY | PURDUE RESEARCH FOUNDATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| EP-1994000-A2 | WATER-SOLUBLE CC-1065 ANALOGS AND THEIR CONJUGATES | Syntarga B.V. (NL) | 2008-11-26 | — | — | EP | claimed |
| US-20080014632-A1 | Near ultraviolet-wavelength photonic-crystal biosensor with enhanced surface to bulk sensitivity ratio | SRU BIOSYSTEMS, INC. | 2008-01-17 | — | — | US | claimed |
| WO-2008008247-A2 | NEAR ULTRAVIOLET-WAVELENGTH PHOTONIC-CRYSTAL BIOSENSOR WITH ENHANCED SURFACE TO BULK SENSITIVITY RATIO | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2008-01-17 | — | — | WO | claimed |
| US-7312090-B2 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS, INC. (US) | 2007-12-25 | — | — | US | claimed |
| WO-2007089149-A2 | WATER-SOLUBLE CC-1065 ANALOGS AND THEIR CONJUGATES | SYNTARGA B.V. (NL) | 2007-08-09 | — | — | WO | claimed |
| US-7153702-B2 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS, INC. (US) | 2006-12-26 | — | — | US | claimed |
| US-20060281077-A1 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS, INC. | 2006-12-14 | — | — | US | claimed |
| US-20030068657-A1 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS LLC (US) | 2003-04-10 | — | — | US | claimed |
| US-5747244-A | COVALENTLY BONDED TO ADSORBED POLYPEPTIDE VIA CROSSLINKING AGENT | CHIRON CORPORATION (US) | 1998-05-05 | — | — | US | claimed |
| US-5712383-A | Process for immobilizing nucleic acid probes on polystyrene surfaces | CHIRON CORPORATION (US) | 1998-01-27 | — | — | US | claimed |